Mesa Laboratories INC /CO/ Form 4 insider transactions

Mesa Laboratories' Chief Financial Officer, John Sakys, reported the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations.

Mesa Laboratories, Inc. CFO John Sakys has been granted 8,133 Restricted Stock Units (RSUs) as part of his compensation, vesting over three years.

Mesa Laboratories, Inc. (MLAB) announced that Brian David Archbold, SVP Operations, was granted 7,346 Restricted Stock Units (RSUs) as part of his compensation, vesting over three years.

Mesa Laboratories' President and CEO, Gary M. Owens, reported the acquisition of 24,659 Restricted Stock Units (RSUs) on June 15, 2025, as part of a pre-arranged plan.

Mesa Laboratories' President and CEO, Gary M. Owens, reported the acquisition of shares through RSU vesting and performance share units, followed by a sale of shares to cover income tax obligations.

Mesa Laboratories' SVP of Operations, Brian Archbold, reported the acquisition of shares through RSU and performance share unit vesting, followed by a sale of a portion of his common stock holdings.

Mesa Laboratories CFO John Sakys filed a Form 4 detailing the acquisition of shares through RSU vesting and performance share units, alongside a sale of common stock.

Mesa Laboratories' Chief Financial Officer, John Sakys, filed a Form 4 disclosing the expiration of 4,087 unexercised non-qualified stock options on June 10, 2025.

Mesa Laboratories' SVP of Operations, Brian David Archbold, reported the expiration of 2,129 unexercised non-qualified stock options on June 10, 2025.

Mesa Laboratories' President and CEO, Gary M. Owens, reported the expiration of 9,939 unexercised non-qualified stock options with an exercise price of $203.54 on June 10, 2025.

Gary Owens, President and CEO of Mesa Laboratories, exercised stock options and sold 21,000 shares of common stock on March 19, 2025, according to a pre-arranged Rule 10b5-1 trading plan.

Director John James Sullivan disposed of 2,000 shares of Mesa Laboratories stock on November 19, 2024, while also holding 44,780 shares indirectly through a trust.

Gary Owens, President and CEO of Mesa Laboratories, reports the acquisition and disposal of company stock related to performance share units and tax liabilities.

Brian David Archbold, SVP Operations at Mesa Laboratories, sold 1,499 shares of common stock at $125 per share on September 13, 2024, under a pre-arranged 10b5-1 trading plan.

John Sakys, CFO of Mesa Laboratories, reports the vesting and disposal of restricted stock units and common stock transactions on September 1, 2024.

Gary Owens, President and CEO of Mesa Laboratories, reports the vesting and disposal of restricted stock units.

Brian David Archbold, SVP of Operations at Mesa Laboratories, reports the vesting and disposal of restricted stock units.

Director John James Sullivan of Mesa Laboratories reports acquisition and disposal of common stock and Restricted Stock Units (RSUs) on September 1, 2024, including a gift of shares to a spousal lifetime access trust.

Director Tony Tripeny reports the vesting and disposal of Restricted Stock Units (RSUs) resulting in the acquisition and disposal of common stock.

Director Shiraz Shabanali Ladiwala reports the vesting and disposal of Restricted Stock Units (RSUs) into common stock of Mesa Laboratories on September 1, 2024.

Director Shannon Hall reports the vesting and disposal of Restricted Stock Units (RSUs) into common stock of Mesa Laboratories on September 1, 2024.

Director Jennifer Alltoft reports the vesting and disposal of Restricted Stock Units (RSUs) into common stock of Mesa Laboratories on September 1, 2024.

Director Shiraz Shabanali Ladiwala acquired 1,949 Restricted Stock Units (RSUs) in Mesa Laboratories Inc /CO/ on August 15, 2024, which vest on August 15, 2025.

Director Shannon Hall acquired 1,404 Restricted Stock Units (RSUs) of Mesa Laboratories on August 15, 2024, which vest on August 15, 2025.

Director Tony Tripeny reports acquisition of 1,404 Restricted Stock Units (RSUs) in Mesa Laboratories.

Director John James Sullivan acquired 1,404 Restricted Stock Units (RSUs) in Mesa Laboratories Inc. on August 15, 2024, which vest on August 15, 2025.

Director Jennifer Alltoft acquired 1,404 Restricted Stock Units (RSUs) of Mesa Laboratories on August 15, 2024, which vest on August 15, 2025.

Director Mark Christopher Capone reports acquisition and disposal of Mesa Laboratories Inc. common stock and Restricted Stock Units (RSUs) on August 15, 2024.

Brian David Archbold, SVP of Operations at Mesa Laboratories, acquired 7,516 Restricted Stock Units (RSUs) on June 18, 2024, which vest in three annual installments starting June 18, 2025.

Gary M. Owens, President and CEO of Mesa Laboratories, Inc., was granted 25,607 restricted stock units (RSUs) on June 18, 2024, which vest in three annual installments starting June 18, 2025.